Cargando…
Enhanced CXCR4 Expression Associates with Increased Gene Body 5-Hydroxymethylcytosine Modification but not Decreased Promoter Methylation in Colorectal Cancer
In colorectal cancer (CRC), upregulation of the C-X-C motif chemokine receptor 4 (CXCR4) is correlated with metastasis and poor prognosis, highlighting the need to further elucidate CXCR4’s regulation in CRC. For the first time, DNA methylation and 5-hydroxymethylcytosine aberrations were investigat...
Autores principales: | Stuckel, Alexei J., Zhang, Wei, Zhang, Xu, Zeng, Shuai, Dougherty, Urszula, Mustafi, Reba, Zhang, Qiong, Perreand, Elsa, Khare, Tripti, Joshi, Trupti, West-Szymanski, Diana C., Bissonnette, Marc, Khare, Sharad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139960/ https://www.ncbi.nlm.nih.gov/pubmed/32110952 http://dx.doi.org/10.3390/cancers12030539 |
Ejemplares similares
-
Correction: Stuckel, et al.; Enhanced CXCR4 Expression Associates with Increased Gene Body 5-Hydroxymethylcytosine Modification but Not Decreased Promoter Methylation in Colorectal Cancer. Cancers 2020, 12, 539
por: Stuckel, Alexei J., et al.
Publicado: (2020) -
Sprouty4 is epigenetically upregulated in human colorectal cancer
por: Stuckel, Alexei J., et al.
Publicado: (2022) -
Epigenetic DNA Modifications Upregulate SPRY2 in Human Colorectal Cancers
por: Stuckel, Alexei J., et al.
Publicado: (2021) -
CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies
por: Khare, Tripti, et al.
Publicado: (2021) -
Proteomics approaches for early detection and targeted therapy of hepatocellular carcinoma
por: Khare, Tripti, et al.
Publicado: (2017)